Keratinocyte carcinomas, basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC) are the most prevalent cancers globally. 1,2 Invasive cSCC makes up 20% of keratinocyte carcinomas. 3 The estimated metastasis rate of primary cSCC is 3-7%, and the prognosis of metastatic disease is poor. [2][3][4][5][6][7] At present, the incidence of cSCC is growing worldwide. 1,2,8 In the process of cSCC development, premalignant lesion, actinic keratosis (AK), progresses to cSCC in situ (cSCCIS) and subsequently to invasive primary cSCC, which can be metastatic. Ultraviolet radiation is the most important risk factor for cSCC, and immunosuppression and chronic ulcers are other important predisposing factors. 5,9 Furthermore, chronic inflammation plays a role in the development and progression of cSCC. 9